semaglutide eye side effects linked to higher risk of vision problems, FDA data analysis shows Incretin Mimetrics - Ozempic, Wegovy,

The two medications work through different pathways, so they complement each other without direct interactions

On average, people on GLP-1 medication lose 14-20% of their weight in a year

Many women struggle with weight loss not just because of eating habits, but due to thyroid dysfunction, insulin resistance, or hormonal imbalances that need to be addressed alongside GLP-1/GIP therapy

Coverage for obesity drugs has historically been limited but is improving

These two conditions serve as a model of a physiological versus a pathological state where conditions such as obesity can promote an increase in the CB1 ligands, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and thus competition for the CB1 receptor